Cargando…

FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population

BACKGROUND: As fat and obesity play a vital role in the pathophysiology of metabolic dysfunction-associated fatty liver disease (MAFLD), this study aims to investigate the association between the fat mass and obesity-associated gene (FTO) and MAFLD. METHODS: Six SNPs (rs6499640, rs1421085, rs8050136...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Zhan, Bi, Yan, Yuan, Fan, Wang, Ruirui, Li, Dong, Wang, Jianying, Hu, Xiaojuan, He, Guang, Zhang, Lei, Liu, Bao-cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429205/
https://www.ncbi.nlm.nih.gov/pubmed/32848374
http://dx.doi.org/10.2147/CIA.S254740
_version_ 1783571241278373888
author Gu, Zhan
Bi, Yan
Yuan, Fan
Wang, Ruirui
Li, Dong
Wang, Jianying
Hu, Xiaojuan
He, Guang
Zhang, Lei
Liu, Bao-cheng
author_facet Gu, Zhan
Bi, Yan
Yuan, Fan
Wang, Ruirui
Li, Dong
Wang, Jianying
Hu, Xiaojuan
He, Guang
Zhang, Lei
Liu, Bao-cheng
author_sort Gu, Zhan
collection PubMed
description BACKGROUND: As fat and obesity play a vital role in the pathophysiology of metabolic dysfunction-associated fatty liver disease (MAFLD), this study aims to investigate the association between the fat mass and obesity-associated gene (FTO) and MAFLD. METHODS: Six SNPs (rs6499640, rs1421085, rs8050136, rs3751812, rs9939609 and rs9930506) within FTO were genotyped for 741 MAFLD patients (median age, 69.98; interquartile range, 66.55–75.93) and 825 healthy people (median age, 69.94; interquartile range, 66.39–75.64). Allele and genotype frequencies, pairwise linkage disequilibrium (LD) and haplotype analysis were calculated. RESULTS: BMI, waist circumference, systolic blood pressure, diastolic blood pressure, fasting plasma glucose, triglyceride, alanine transaminase, glutamyl transpeptidase and the prevalence of diabetes were found to be higher in the MAFLD individuals comparing to the control ones (P < 0.05). For rs1421085, the C allele frequency was remarkably higher in MAFLD after Bonferroni correction (OR [95% CI] =1.353 [1.095–1.671]; P(corr) =0.030), and a significantly different genotype result was observed in log-additive model (OR [95% CI] =1.369 [1.108–1.691]; P(corr) =0.024). For rs8050136, significantly increased A allele frequency was observed in MAFLD (OR [95% CI] =1.371 [1.109–1.695]; P(corr) =0.024), and A-allele carriers showed increased MAFLD risk (OR [95% CI] =1.393 [1.103–1.759]; P(corr) =0.030). For rs3751812, the T allele frequency was remarkably higher in MAFLD (OR [95% CI] =1.369 [1.108–1.691]; P(corr) =0.024), and T-allele carriers demonstrated high MAFLD risk (OR [95% CI] =1.392 [1.103–1.756]; P(corr) =0.030). For rs9939609, A allele frequency was also remarkably high in MAFLD (OR [95% CI] =1.369 [1.108–1.691]; P(corr) =0.024), and A-allele carriers were more susceptible to MAFLD (OR [95% CI] =[1.103–1.756]; P(corr) =0.030). A strong LD was found among rs1421085, rs8050136, rs3751812 and rs9939609 (r(2) >0.8), and individuals with C-A-T-A haplotype had an elevated MAFLD risk (P =0.005). CONCLUSION: The case-control study indicated that C variant of rs1421085, A variant of rs8050136, T variant of rs3751812 and A variant of rs9939609 are associated with elevated MAFLD risk in the older Chinese Han population.
format Online
Article
Text
id pubmed-7429205
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-74292052020-08-25 FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population Gu, Zhan Bi, Yan Yuan, Fan Wang, Ruirui Li, Dong Wang, Jianying Hu, Xiaojuan He, Guang Zhang, Lei Liu, Bao-cheng Clin Interv Aging Original Research BACKGROUND: As fat and obesity play a vital role in the pathophysiology of metabolic dysfunction-associated fatty liver disease (MAFLD), this study aims to investigate the association between the fat mass and obesity-associated gene (FTO) and MAFLD. METHODS: Six SNPs (rs6499640, rs1421085, rs8050136, rs3751812, rs9939609 and rs9930506) within FTO were genotyped for 741 MAFLD patients (median age, 69.98; interquartile range, 66.55–75.93) and 825 healthy people (median age, 69.94; interquartile range, 66.39–75.64). Allele and genotype frequencies, pairwise linkage disequilibrium (LD) and haplotype analysis were calculated. RESULTS: BMI, waist circumference, systolic blood pressure, diastolic blood pressure, fasting plasma glucose, triglyceride, alanine transaminase, glutamyl transpeptidase and the prevalence of diabetes were found to be higher in the MAFLD individuals comparing to the control ones (P < 0.05). For rs1421085, the C allele frequency was remarkably higher in MAFLD after Bonferroni correction (OR [95% CI] =1.353 [1.095–1.671]; P(corr) =0.030), and a significantly different genotype result was observed in log-additive model (OR [95% CI] =1.369 [1.108–1.691]; P(corr) =0.024). For rs8050136, significantly increased A allele frequency was observed in MAFLD (OR [95% CI] =1.371 [1.109–1.695]; P(corr) =0.024), and A-allele carriers showed increased MAFLD risk (OR [95% CI] =1.393 [1.103–1.759]; P(corr) =0.030). For rs3751812, the T allele frequency was remarkably higher in MAFLD (OR [95% CI] =1.369 [1.108–1.691]; P(corr) =0.024), and T-allele carriers demonstrated high MAFLD risk (OR [95% CI] =1.392 [1.103–1.756]; P(corr) =0.030). For rs9939609, A allele frequency was also remarkably high in MAFLD (OR [95% CI] =1.369 [1.108–1.691]; P(corr) =0.024), and A-allele carriers were more susceptible to MAFLD (OR [95% CI] =[1.103–1.756]; P(corr) =0.030). A strong LD was found among rs1421085, rs8050136, rs3751812 and rs9939609 (r(2) >0.8), and individuals with C-A-T-A haplotype had an elevated MAFLD risk (P =0.005). CONCLUSION: The case-control study indicated that C variant of rs1421085, A variant of rs8050136, T variant of rs3751812 and A variant of rs9939609 are associated with elevated MAFLD risk in the older Chinese Han population. Dove 2020-08-11 /pmc/articles/PMC7429205/ /pubmed/32848374 http://dx.doi.org/10.2147/CIA.S254740 Text en © 2020 Gu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Gu, Zhan
Bi, Yan
Yuan, Fan
Wang, Ruirui
Li, Dong
Wang, Jianying
Hu, Xiaojuan
He, Guang
Zhang, Lei
Liu, Bao-cheng
FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population
title FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population
title_full FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population
title_fullStr FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population
title_full_unstemmed FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population
title_short FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population
title_sort fto polymorphisms are associated with metabolic dysfunction-associated fatty liver disease (mafld) susceptibility in the older chinese han population
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429205/
https://www.ncbi.nlm.nih.gov/pubmed/32848374
http://dx.doi.org/10.2147/CIA.S254740
work_keys_str_mv AT guzhan ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation
AT biyan ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation
AT yuanfan ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation
AT wangruirui ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation
AT lidong ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation
AT wangjianying ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation
AT huxiaojuan ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation
AT heguang ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation
AT zhanglei ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation
AT liubaocheng ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation